On June 7, 2018, the United States Patent and Trademark Office (USPTO) issued another memorandum on patent eligibility: the Vanda Memo (click here to view PDF copy). The memo is based on a recent case decided by the Federal Circuit, Vanda Pharmaceuticals Inc. v. West-Ward Pharmaceuticals.